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We retrospectively reviewed the medical records of 189
children who were admitted to the Pediatric Neurology
Department at Yonsei University College of Medicine with
status epilepticus (SE) between April, 1994 and April, 2003.
The children were followed up for a mean duration of 17
months. We analyzed the clinical findings and the relationships
between neurologic sequelae, recurrence, age of onset,
presumptive causes, types of seizure, seizure duration and the
presence of fever. Mean age at SE onset was 37 months.
Incidences by seizure type classification were generalized
convulsive SE in 73.5%, and non-convulsive SE in 26.5%. The
incidences of presumptive causes of SE were idiopathic 40.7%,
epilepsy 29.1%, remote 16.4% and acute symptomatic in
13.3%. Among all the patients, febrile episodes occurred in
35.4%, especially in patients under 3 year old, and 38.4% of
these were associated with febrile illness regardless of pre-
sumptive cause. Neurologic sequelae occurred in 33% and the
mortality rate was 3%. Neurologic sequelae were lower in
patients that presented with an idiopathic etiology and higher
in generalized convulsive SE patients. The recurrence of SE
was higher in patients with a remote symptomatic epileptic
etiology, and generalized convulsive SE showed higher rates
of recurrence. Based on this retrospective study, the neurologic
outcomes and recurrence of SE were found to be strongly
associated with etiology and seizure type. Age, seizure
duration and the presence of febrile illness were found to have
no effect on outcome.
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INTRODUCTION
Status epilepticus (SE) is a common neurologi-
cal emergency that is sometimes associated with
high morbidity and mortality. Approximately 10
to 12% of children and adults that experience a
first unprovoked seizure1-3 or who are newly
diagnosed as having epilepsy1,4 request medical
attention for SE. Several clinical series have pres-
ented information concerning some important
clinical features of SE and predictive indicators of
its outcome. Several studies indicate that neuro-
logic outcome seems to be dependent on age and
etiology. Neurologic outcome is worse in elderly
patients, patients with an acute symptomatic
causes or both.5-8 In a study by Maytal et al., neu-
rologic sequelae of convulsive SE were found age
dependent, and to occurr in 6% of those over 3
years old but in 29% of patients under 1 year old.9
In this study, we analyzed our data to identify
factors predicting the neurologic outcome and
recurrence of SE.
MATERIALS AND METHODS
The study group included all patients younger
than 15 years of age who were admitted with a
diagnosis of status epilepticus to the Department
of Pediatric Neurology, Yonsei University College
of Medicine between April 1995 and April 2003.
The 189 cases were reviewed with respect to
seizure history, electrophysiologic data, the imme-
diate precipitating seizure etiology, outcome, labo-
ratory studies and hospital course.
Seizure types and causes were classified accord-
ing to the International League of AntiEpilepsy
classification and guideline for epidemiological
research. Status epilepticus was defined as any
seizure lasting for 30 minutes or longer or inter-
mittent seizures lasting for more than 30 minutes
from which the patient did not regain conscious-
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ness. Acute symptomatic cause was defined as
any seizure originating from a CNS insult such as
anoxia, CVA, hemorrhage, trauma, tumor or a meta-
bolic etiology. A remote symptomatic etiology was
defined as one having no acute precipitating etio-
logy, but with a previous history of CNS insult.
An idiopathic etiology was defined as seizures
not associated with any identifiable cause of
seizure initiation.
We used statistical methods that took into ac-
count the time dependent nature of the data.
Univariate and multivariate analysis were perfor-
med using the Cox proportional hazards models.
Risk ratio were used as a measures of the mag-
nitude of the association between variables and
the risk of a measured outcome. 95% confidence
intervals were calculated using a logistic regres-
sion models using a formula based on a normal
approximation. The Pearson's chi-square test was
also used. A p value of < 0.05 was considered
statistically significant.
RESULTS
Age and sex distribution of patients
The SE population was 59% male and 41%
female.
Forty-nine (26%) patients were under the age of
1 year, and 64 patients(34%) were between 1 and
3 years (Fig. 1).
Children less than 3 years of age represented a
subgroup of the pediatric population with the
highest incidence of SE.
Etiologies of SE
The main etiology in children was idiopathic
and accounted of 40.7% of the cases. The epileptic,
the remote symptomatic and the acute sympto-
matic etiology groups also accounted for a signifi-
cant number of cases in children (Fig. 2). Patients
with febrile SE represented 35.4% of all patient
regardless of etiology. 38.4% of patients under 3
years of age experienced febrile illness.
Seizure types
73.6% of SE seizures were generalized con-
vulsive and 26.4% nonconvulsive. Nonconvulsive
SE was subdivided into myoclonic, partial and
Fig. 1. Age and sex distributions of the patients.
Fig 2. Etiologies of SE in children.
Etiologies included Idiopathic,
Acute symptomatic (CNS infection,
Metabolic, Anoxia, ICH, Trauma),
Remote (Remote symptomatic), and
Epilepsy. Data are expressed as the
numbers and percentages of cases
with each etiology.
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absence SE. Complex partial SE was more com-
mon than other nonconvulsive SE. Absence SE
was uncommon in this study. Generalized convul-
sive SE was further divided into generalized
tonic-clonic or tonic SE (Table 1).
Outcomes
A neurologic sequela was present in 62 cases
(33%) (Fig. 3). We analyzed data for factors
precicting neurologic outcome i.e., age of onset,
presumptive cause, types of seizure, seizure dura-
tion and the presence of fever. 79.4% of all SE
patients showed a generalized seizure pattern,
and generalized seizure was found to be asso-
ciated with a poor neurologic outcome. SE with an
idiopathic etiology showed a better neurologic
outcome than the other etiologies (Table 2).
Among 55 patients less than 1 year old, 29.1%
showed neurologic sequelae. 34.3% of 134 patients
over 1 year old showed a poor neurologic out-
come, but there wad no significant statistical
difference between the two age groups. 70.9% of
patients had a short duration of seizure of < 1
hour, and among SE patients, 35.4% of cases had
experienced an associated febrile illness, but these
two factors did not affect the prevalence of
neurologic SE sequelae.
Table 2. Multivariate Analysis of Factors Associated with a Increased Risk of Neurologic Sequelae
Risk of neurologic sequels
Risk Ratio 95% CI p
Generalized seizure 2.53 1.15 - 5.58 0.01
Idiopathic etiology 0.28 0.13 - 0.59 < 0.01
Table 1. Incidence of SE According to Classification
Seizure type No. of cases (%)
Generalized Covulsive SE 139 (73.6)
Tonic-clonic 102 (54)
Tonic 37 (19.6)
Nonconvulsive SE 50 (26.4)
Myoclonic 8 (4.2)
Absence 3 (1.6)
Partial 39 (20.6)
Simple partial 1
Complex partial 38
Table 3. Multivariate Analysis of Factors Associated with a Increased Risk for Recurrent SE
Risk of recurrent SE
Risk Ratio 95% CI p
Generalized seizure 6.83 1.53 - 30.42 0.01
Epilepsy 4.51 1.60 - 12.66 < 0.01
Remote symptomatic 3.21 1.08 - 9.52 0.03
Fig. 3. Neurologic outcomes according to etiologies. Etio-
logies included Idiop (Idiopathic), Acute symptomatic,
Remote symptomatic and Epilepsy. Neurologic sequelae
including motor and cognitive deficits and significantly
lower in those with an idiopathic etiology than in those
with other causes (*p < 0.01).
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Among the 189 patients with SE, 30 (16%) expe-
rienced recurrent episodes. The risk factors for a
higher rate of recurrent SE are presented in Table
3.
Generalized convulsive seizure, patients with
epilepsy and a remote symptomatic etiology
showed a higher rate of recurrent SE.
The overall mortality rate among patients group
was 3%. The mortality rate was 11.6% among
acute symptomatic cases, and 6.5% among remote
symptomatic cases. The mortality rate was highest
in acute symptomatic cases.
History of epilepsy
The majority of SE patients in this study did not
have a previous history of epilepsy.
Only 29% of patients that presented with SE
had a previous history of epilepsy, indicating that
nonepileptic individuals also have a high risk of
developing SE.
DISCUSSION
In 1981, the International League against Epi-
lepsy defined status epilepticus as a seizure that
‘persist for a sufficient length of time or is re-
peated frequently enough that recovery between
attack does not occur’.10 Some studies have
defined status epilepticus as seizures that persist
for 20 to 30 minutes,
11-13
or as seizures of more
than 30 minutes of continuous seizure activity or
two or more sequential seizures without full
recovery of consciousness between seizures.11,12 In
some other studies, including the VA Coop-
erative Trial on the Treatment of Generalized
Convulsive Status Epilepticus14 and the Pre-Hos-
pital Treatment of Status Epilepticus (PHTSE)
study,15 seizure duration of 10 and 5 minutes were
used, respectively as SE inclusion criteria. However
from the clinical aspect, a definition of a short
duration is not widely accepted. So we used the
definition that status epilepticus is a seizure
lasting over 30 minutes.
DeLorenzo et al. identified patients with pro-
longed seizures that lasted between 10 and 29
minutes and in the present study, seizures of this
duration were quite common, and almost one half
would spontaneously terminated without treat-
ment.16
However all investigators agree that the initia-
tion of treatment should begin early to avoid
potential neuronal damage secondary to pro-
longed seizure activity.17 The incidence of SE has
been estimated at 10 to 41 cases per 100,000 peo-
ple per year, totaling some 100,000 to 160,000
patients per year in the United States.18-20 About
10 to 12% of children and adults that experience
a first unprovoked seizure1-3 or with newly
diagnosed epilepsy1,4 present for medical attention
with SE. Approximately 5% of adults and 10% to
25% of children with epilepsy will have at least
one episode of SE,21 whereas 13% of all patients
with SE will have a recurrent bout.22 The recur-
rence of SE in the Richmond population was
13.3%18 whereas in our study the recurrence rate
was 16%. A remote symptomatic etiology and a
young age have long been recognized as risk
factors for SE4,11,18,23,24 and recurrent SE.25,26
Shinnar et al. found that 40% of cases among
children occurred in those younger than 2 years.23
Moreover, the risk of recurrence is greatest in
children with acute and chronic central nervous
system insults.25
Our data showed somewhat different features.
A remote symptomatic etiology and a previous
history of epilepsy were risk factors of recurrent
SE, but acute symptomatic etiology did not show
significant difference in terms of neurologic out-
come. Moreover, age of onset seemed to be unre-
lated to the rate of recurrence. Fever and infection
are the most common causes of generalized
convulsive SE in children younger than 2 years of
age without a history of epilepsy. However,
preexisting epilepsy and low AED levels still
remain the primary causes in older children, and
appropriate attention to AED levels is war-
ranted.23,25 Remote neurologic insults such as head
trauma can also cause SE.
3,9
In our study, fever related episodes occurred in
38.4% of children younger than 3 years of age, but
this febrile illness did not affect neurologic out-
come or SE recurrence.
It is now well and widely accepted that SE can
be injurious to the mature brain.
The fundamental pathophysiology of SE in-
volves a failure of mechanisms that normally
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abort an isolated seizure. This failure can arise
from abnormally persistent excessive excitation or
the ineffective recruitment of inhibition.27
Induced seizures may be prolonged by a failure
of the GABA-mediated suppression of an acti-
vated focus. This resistance may develop through
the seizure-induced formation of varying isoforms
of the GABA type A receptor in the hippocam-
pus.28,29 Alternatively, SE may be perpetuated by
sustained N-methyl-D-aspartate (NMDA)-medi-
ated neuronal stimulation.30 In animal models, SE
developed a sensitivity to NMDA antagonist in
parallel with the development of GABAA resis-
tance.31,32 The presumed mechanism of neurologic
injury is via glutamate activation of NMDA
receptors leading to programmed cell death.22 The
accidental ingestion of mussels contaminated with
the neurotoxin domoate, a structural analog of
glutamate and kainate, has been reported to cause
a profound encephalopathy and prolonged sei-
zures in some patients.33,34
Moreover, SE can be caused by penicillin and
related compounds that antagonize the effect of
GABA.35 Thirty minutes before, convulsive status
epilepticus the glucose and oxygen requirement of
the brain are increased. Initially these metabolic
demands are met by the dilation of cerebral blood
vessels and increases in blood flow.36
But, 30 minutes after seizure, blood pressure
and cerebral blood flow reduce and this results in
the accumulation of toxic metabolites and inade-
quate oxygenation.37 Thus SE lasting 30 to 45
minutes can cause cerebral injury, especially to
limbic structures like the hippocampus, and the
seizure itself is sufficient to damage the central
nervous system.38,39
However, the continuing seizure activity also
contributes to neuronal damage, independent of
systemic factors.40 Such neuronal damage during
prolonged SE may be due in part to the action of
excitatory neurotransmitters, which cause an in-
flux of calcium into neurons.41
Prolonged seizures even with control of asso-
ciated systemic disturbances can directly cause
cerebral damage.
42,43
The morbidity and mortality
of SE has been suggested to be related to three
major factors44: damage to the CNS caused by the
initial insult causing SE, systemic stress from
repeated convulsions, and direct injury to the
brain due to severe electrical discharges within
the central nervous system.
One review of morbidity and mortality rates
among children with SE showed neurologic com-
plication rates of 29% among infants younger than
1 year. 11% among children aged 1 to 3 years and
6% among children older than 3 years of age. In
30% of patients, a chronic seizure disorder devel-
oped and the mortality rate was approximately
3%.9 Some studies have suggested that the mor-
tality rate among people with SE ranges 6% to
30%.45-47
Etiology has repeatedly been proven to be the
major determinant of SE mortality.7,48,49 Although
children have a high incidence of SE, there is a
much lower overall rate of mortality in the pedi-
atric population than in the adult popula-
tion.8,18,19,50,51 Permanent neurologic sequelae other
than subsequent seizures have been noted in 9%
to 28% of children.52 The frequency of neurologic
sequelae is highest in children when SE is caused
by an acute CNS insult.52 Several studies have
shown that the duration of seizure is strongly
associated with the ultimate outcome. Moreover,
in status epilepticus lasting longer than one hour,
outcome is poor.53 The mortality rate increased
fivefold in those in the acute symptomatic group
with SE lasting over 24 hours.54 Age also seems
to be a clear prognostic factor, but when corrected
for etiology, it becomes less significant.7
In the present study, the mortality rate was 3%,
but among etiologies, an acute symptomatic eti-
ology exhibited the highest mortality. Patients
with an idiopathic etiology showed a significantly
lower incidence of neurologic sequelae than other
causes of SE. Acute symptomatic, remote sympto-
matic and a previous history of epilepsy show
higher rates of neurologic sequelae. However age
of onset and duration of seizure were not found
to be significantly related with neurologic out-
come. It is not clear why age of onset and seizure
duration did not affect neurologic outcome. But
71% of patients had a duration of seizure of < 1
hour, perhaps this due to improved management
technicques. Based on these results of our retro-
spective study, we conclude that an idiopathic SE
etiology is a favorable predictor of a better neu-
rologic outcome and lower SE recurrence and that
generalized convulsive SE an indicator of worse
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outcomes. However, age of onset and duration of
seizure were not found to affect neurologic out-
come and SE recurrence.
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